MENU
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
432.56M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
10.46M
Revenue
N/A
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
9.66 USD as % of share price
Fundamentals
RNAC
Capitalization
433M
P/E Ratio
N/A
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
10.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.66%
Revenue
N/A
ROE
N/A
Book Value
-116.8M
P/B Ratio
588.24
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.03
Current Revenue Per Employee
153684.20
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
120M
Shares Outstanding - Current
25.4M
Total Liabilities
442M
Total Volume MTD
N/A
Value
-1
Gain YTD
-17.706
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of targeted immunotherapies and vaccines to treat and prevent diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com